Table 2. Vaccine status of MSS and dMMR groups.
MSS (n=38) | dMMR (n=38) | p-Value | |
BNT162b2 (n, %) | |||
Yes | 24 (63.2) | 33 (86.8) | 0.01 |
No | 14 (36.8) | 5 (13.2) | |
BNT162b2 dose (n, %) | |||
1 dose | 6 (25) | 6 (18.1) | |
2 doses | 13 (54.1) | 19 (57.6) | |
3 doses | 5 (20.9) | 6 (18.1) | |
4 doses | 0 | 2 (6.2) | |
CoronaVac (Sinovac) (n, %) | |||
Yes | 28 (73.7) | 23 (60.1) | 0.32 |
No | 10 (26.3) | 15 (39.9) | |
CoronaVac dose (n, %) | |||
2 doses | 19 (67.9) | 19 (82.6) | |
3 doses | 9 (32.1) | 4 (17.4) |